EUVIMEDEUVIMED entdecken
Fallbericht

Sulfasalazine-induced aseptic meningitis

Emily McHale iD, Andrew Dermawan iD, Raymond Tang, Lisa Redgrave

Modern Rheumatology Case Reports · 29.06.2026 · 10 (2)

DOI: 10.1093/mrcr/rxag071 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Modern Rheumatology Case Reports, online erschienen am 10.07.2026. Verfasst von Emily McHale und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Medicine, Sir Charles Gairdner Hospital, Nedlands, WA, Australia. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Non-Steroidal, Antirheumatic Agents, Meningitis, Aseptic, Sulfasalazine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aseptic meningitis is a clinical syndrome of meningeal inflammation without clear infectious aetiology. Drug-induced aseptic meningitis is a well-documented but poorly understood side effect of a variety of medications, and has rarely been described with the immunosuppressive and anti-inflammatory drug sulfasalazine. This report describes the case of a man in his 60s presenting with aseptic meningitis after commencing sulfasalazine for seronegative arthritis 1 month prior. Analysis of cerebrospinal fluid showed a predominantly mononuclear leucocytosis, slightly elevated protein, and normal glucose. Cerebrospinal fluid microscopy, culture, sensitivities, and polymerase chain reaction testing were negative for bacterial and viral causes of meningitis. The patient improved with cessation of sulfasalazine. Antimicrobial treatment was ceased with ongoing resolution of symptoms, supporting a diagnosis of sulfasalazine-induced aseptic meningitis. Clinicians should consider a diagnosis of sulfasalazine-induced aseptic meningitis when other aetiologies of meningitis have been excluded, particularly in the first weeks to months of commencing sulfasalazine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Inflammatory Agents, Non-SteroidalAntirheumatic AgentsMeningitis, AsepticSulfasalazineHumansMale

Stichwörter der Autor:innen

DIAMDMARDSIAMSulfasalazinedrug reaction

Substanzen

Anti-Inflammatory Agents, Non-SteroidalAntirheumatic AgentsSulfasalazine

Autor:innen und Institutionen

  • Department of General Medicine, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.
  • Department of Pharmacy, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.

ORCID-Profile: Emily McHale, Andrew Dermawan

Zitieren

APA

McHale, E., Dermawan, A., Tang, R., & Redgrave, L. (2026). Sulfasalazine-induced aseptic meningitis. Modern Rheumatology Case Reports, 10(2). https://doi.org/10.1093/mrcr/rxag071

Vancouver

McHale E, Dermawan A, Tang R, Redgrave L. Sulfasalazine-induced aseptic meningitis. Modern Rheumatology Case Reports. 2026;10(2). doi:10.1093/mrcr/rxag071

BibTeX
@article{McHale2026,
  author = {McHale, Emily and Dermawan, Andrew and Tang, Raymond and Redgrave, Lisa},
  title = {Sulfasalazine-induced aseptic meningitis},
  journal = {Modern Rheumatology Case Reports},
  year = {2026},
  volume = {10},
  number = {2},
  doi = {10.1093/mrcr/rxag071}
}
Kostenlos starten →